REG - capAI PLC - Soft Launch of Author42

capAIAnnouncement

18/11/2025 07:02

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251118:nRSR8883Ha&default-theme=true

RNS Number : 8883H  capAI PLC  18 November 2025

THIS ANNOUNCEMENT ("ANNOUNCEMENT") AND THE INFORMATION CONTAINED HEREIN IS
RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR
INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, ITS
STATES, TERRITORIES AND POSSESSIONS ("UNITED STATES"), AUSTRALIA, CANADA,
JAPAN, SINGAPORE, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN
WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE PROHIBITED BY ANY
APPLICABLE LAW.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF
REGULATION 2014/596/EU, WHICH IS PART OF THE DOMESTIC LAW OF THE UNITED
KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND ("UK") PURSUANT TO THE MARKET
ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE
PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK
MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

18 November 2025

capAI plc

(the "Company" and, together with its subsidiaries and subsidiary
undertakings, the "Group" or "capAI")

 

Soft Launch of Author42

 

capAI plc (LSE: CPAI; OTCQB: CPIQF) is pleased to announce the soft launch
of Author42, an advanced generative‑AI platform designed to revolutionise
non-fiction book creation for authors, editors and publishing teams. Developed
by the Company's U.S. subsidiary, capMedia Inc. ("capMedia"), Author42
combines market‑driven insight, AI‑scaffolding and professional editorial
workflows into a unified author‑centric offering.

 

Public Beta Completed: Transition to Soft Launch

 

The soft launch follows a 12-week public beta programme, during which the
platform's core systems operated in a live environment and the Company
completed its planned evaluation of Author42's functionality, stability, and
overall readiness of the platform's rollout.

 

A Platform Built for Professional Authoring

 

Author42 empowers authors from idea through publication with the following key
capabilities:

 

·      AI‑Powered Book Blueprint: Generates a custom book proposal and
table of contents - complete with 10 scaffolded chapters - based on the
author's idea and real-time market research, providing structure from the
start.

·      Market Demand Validation: Confirms whether the chosen topic has
real commercial potential before significant writing effort is invested.

·      Author‑Driven Drafting: Authors retain full structural and
content control - whether writing independently or co‑drafting with AI
assistance.

·      Export‑Ready Formatting: Generation of EPUB, PDF and DOCX
files, ready for submission to publishers, agents or self‑distribution.

 

CLARA42: Embedded Professional Editing Intelligence

 

A standout feature of the Author42 platform is CLARA42 (Creative Literary
Assistance for Real Authors), an embedded editorial engine that delivers
professional three-tier editing.

 

CLARA42 ensures every manuscript meets the highest industry standards through:

 

·      Developmental (Structural) Editing: In-depth analysis of book
architecture, logic, and argument flow.

·      Line Editing: Sentence-level refinement to enhance clarity, tone,
and impact.

·      Copy Editing (Style Compliance): Full alignment with The Chicago
Manual of Style, producing publisher-ready output.

 

"With CLARA42 integrated into Author42, we bring professional editing within
reach of every author," said Jayne Lytel, AI Architect at capMedia. "It's more
than spelling and grammar; it's about structure, flow, and stylistic polish,
delivered by AI trained on real editorial standards."

 

Benefits for Authors

 

Key benefits for authors include:

 

·      finishing manuscripts up to 60% faster;

·      reducing planning time from months to days;

·      publishing books aligned with reader demand (not just author
ambition);

·      validating topics before the effort is committed; and

·      increasing completion rates and positioning authors for publisher
acceptance with fully compliant outputs.

 

"Author42 gives authors real‑time clarity and structure," said Lytel.
"Rather than being paralysed by a blank page, authors are now supported by
live market intelligence, AI‑scaffolding and professional editorial
workflows, so they move confidently from idea to finished manuscript."

 

Soft Launch: Final Stage Before Commercial Release

 

The soft launch introduces Author42 to a controlled early-access cohort as the
Company prepares for full commercial rollout. This phase will:

 

·      validate onboarding flows at scale;

·      refine editorial and IP-development workflows;

·      test pricing, packaging, and customer-support readiness; and

·      complete final platform optimisation prior to general release.

 

The Company expects to move from soft launch to full commercial availability
following completion of this structured evaluation period.

 

Pricing and Availability

 

Authors may access the platform at https://www.author42.com
(https://www.author42.com) .

 

Author42 is offered through a tiered subscription structure, beginning with a
free plan and paid plans from US$20 per month. All paid tiers include a 7-day
free trial. Higher-tier plans provide increased functionality, greater token
and word capacity, and access to more advanced export formats and tools. Full
pricing details are available at https://www.author42.com/pricing
(https://www.author42.com/pricing) .

 

Fiction

 

Architectural work is underway to expand to serve fiction authors with
AI-assisted world-building, character development, and VOICE42 (Voice
Optimization & Idiolect Calibration Engine), a breakthrough feature that
creates character-specific linguistic models from uploaded profiles.

 

While competitors flag inconsistencies, VOICE42 generates or refines dialogue
and narration to maintain each character's distinct voice, eliminating
"on-the-nose" exchanges and creating the layered subtext that defines literary
quality.

 

The fiction components of the platform are expected to become available in
early 2026, subject to ongoing development and testing.

 

Comment

 

Professor Ronjon Nag, Executive Director of capAI plc, commented:

"The conclusion of the beta phase reflects a significant period of focused
work behind the scenes as we advanced the core technology and underlying IP of
the Author42 platform. I would like to thank our investors for their patience
and continued support during this development cycle. In my view, this has been
a value-accretive period for the Company in terms of strengthening our IP base
and preparing Author42 for wider commercial deployment. With the planned
additions of Creator42 and Game42 in due course, we expect the broader
platform ecosystem to enhance the economics available to authors and expand
the opportunities for IP development."

 

For the purposes of UK MAR, the person responsible for arranging release of
this Announcement on behalf of capAI is Richard Edwards, Executive Chairman.

 

Enquiries

 

Company:

capAI plc hello@capaiplc.com

 

Broker Enquiries:

AlbR Capital Limited Tel: +44 (0) 207 469 0930

 

Important Legal Information

 

The information contained in this Announcement is for background purposes only
and does not purport to be full or complete, nor does this Announcement
constitute or form part of any invitation or inducement to engage in
investment activity. No reliance may be placed by any person for any purpose
on the information contained in this Announcement or its accuracy, fairness or
completeness. The contents of this Announcement are not to be construed as
legal, financial or tax advice.

 

This Announcement does not constitute or form part of any offer or invitation
to sell or issue, or any solicitation of any offer to purchase or subscribe
for, any securities, nor shall it (or any part of it), or the fact of its
distribution, form the basis of, or be relied on in connection with, any
contract therefor.

 

This Announcement may include forward-looking statements, which are based on
current expectations and projections about future events, including about the
Group's operations, strategy, financial performance, development milestones,
and the future prospects of its business divisions, including capMedia and the
Author42 platform. These statements may include, without limitation, any
statements preceded by, followed by or including words such as "target",
"believe", "expect", "aim", "intend", "may", "anticipate", "estimate", "plan",
"project", "will", "can have", "likely", "should", "would", "could" and any
other words and terms of similar meaning or the negative thereof.

 

Forward-looking statements are based on current expectations and are subject
to various risks and uncertainties that could cause actual outcomes to differ
materially. These risks include, but are not limited to: successful execution
of definitive agreements; regulatory approvals; development timelines; market
acceptance; technological shifts; and broader economic conditions. No
representation or warranty is made or will be made that any forward-looking
statement will come to pass, and no assurance can be given that any
forward-looking statement will prove accurate. Except as required by law,
capAI undertakes no obligation to revise or update any forward-looking
statement. The forward-looking statements in this Announcement speak only as
at the date of this Announcement.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPKOBQDBDBPDD



            Copyright 2019 Regulatory News Service, all rights reserved